• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Apyx Medical Corporation - Common Stock (NQ:APYX)

    2.960 -0.060 (-1.99%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Apyx Medical Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Apyx Medical (APYX) Q2 2026 Earnings Call Transcript ↗
    AYON adoption accelerated 22% as surgeons target GLP-1 weight-loss patients. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring ↗
    Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin... 
    Via MarketBeat
    Apyx Medical (NASDAQ:APYX) Shares Dip Despite Q2 Earnings Beat ↗
    Via Chartmill
    News headline image
    Apyx Medical Q2 Earnings Call Highlights ↗
    Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international... 
    Via MarketBeat
    Topics Earnings
    APYX MEDICAL CORP (NASDAQ:APYX) Surges After Q1 Beat ↗
    Via Chartmill
    APYX Medical Corp (NASDAQ:APYX) Meets Minervini Trend Template with High-Growth Momentum ↗
    Via Chartmill
    Apyx Medical Corp (NASDAQ:APYX) Reports Q4 Revenue Beat and Narrowed Loss ↗
    Via Chartmill
    News headline image
    What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play ↗
    Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide. 
    Via The Motley Fool
    Topics Artificial Intelligence Emissions Energy
    News headline image
    This AI-Focused Cybersecurity Company Is Down 21% in a Year, so Why Is One Fund Buying? ↗
    This cybersecurity firm delivers risk assessment and vulnerability management solutions to enterprise and government clients worldwide. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth ↗
    Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
     
    Via Benzinga
    News headline image
    A Look Ahead: Apyx Medical's Earnings Forecast ↗
     
    Via Benzinga
    News headline image
    What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year ↗
    EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares ↗
    Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Apyx Medical (APYX) Q1 2026 Earnings Transcript ↗
    Apyx Medical (APYX) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    Topics World Trade
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    Navigating the Volatile Currents: AI's Enduring Grip Amidst Shifting Market Sentiments
    As November 20, 2025, unfolds, global financial markets present a landscape of intriguing contrasts, marked by the persistent, transformative power of artificial intelligence and a growing undercurrent... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Earnings
    News headline image
    What's going on in today's after hours session ↗
    As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
    Via Chartmill
    News headline image
    APYX MEDICAL CORP (NASDAQ:APYX) Beats Q3 2025 Earnings Estimates ↗
    Apyx Medical Q3 2025 earnings beat expectations with a 50% EPS surprise and strong revenue. Stock surges on successful AYON Body Contouring System launch. 
    Via Chartmill
    Topics Earnings
    News headline image
    APYX Medical Corp (NASDAQ:APYX) Reports Mixed Q2 2025 Earnings with Revenue Miss and Narrower Loss ↗
    APYX Medical Corp reported Q2 2025 results with revenue of $11.37M, missing estimates, but a narrower EPS loss of -$0.09. Stock shows muted reaction amid commercial expansion plans. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024 ↗
    APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
    From Apyx Medical Corporation
    Via Business Wire
    News headline image
    Earnings Scheduled For March 13, 2025 ↗
     
    Via Benzinga
    News headline image
    Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
    From Apyx Medical Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.